Skip to Main Content
Pitt Home
Find People
School of Medicine
Toggle navigation
Skip Navigation Links
Home
About
Leadership
Mission
Department Statistics
Building Information
Thomas E. Starzl BST
Biomedical Science Tower 3
Directory
Primary Faculty
Secondary Faculty
Graduate Students
Fellows
Administrative Staff
Research Staff
Adjunct Faculty
Department Alumni
Research
Research Areas
Labs
Equipment
Funding Opportunities
Faculty Development Program
Responsible Conduct of Research
Shops
Cell Biology/Pharmacology Electronics Shop
Cell Biology/Pharmacology Machine Shop
Education
Molecular Pharmacology Graduate Program
Current Students
Current Student Roster
Student Publications
Diversity, Accessibility, and Counseling
Student Awards
MPGP News
Prospective Students
Welcome from the Director
Research Opportunities
PhD Track
MD/PhD Track
Financial Aid
Graduate Faculty
Graduate Courses
Grad Student Lab Rotations
Grad Student Events
Grad Student Event Calendar
Graduate Student Event Schedule
Alumni/Career Development
Alumni
Alumni Contacts
Molecular Pharmacology Facebook Group
Molecular Pharmacology Student-Alumni Network (LinkedIn)
SOM Career Development - Explore
Executive Committee
Student Testimonials
IBGP
Grad Student Funding Opportunities
NIH T32 Training Grant
Outcomes
Admissions
Student Handbook & General Timeline
Links
Useful Links
School of Medicine
PubMed
Remote Resources
Biomedical Masters Program
Undergraduate Research
Summer Fellowships
Lab Rotations
News
Events
Calendar
Seminar Series
Links
Contact
Opportunities
Department
PORtal
Computer Resources Access Request
IT-Equipment Support Request
Poster Requests
Reservation Calendars
Home
>
Events
>
Seminar Series
Pharmacology and Chemical Biology Seminar Series
Skip In-Page Navigation
Events
Calendar
Seminar Series
Pharmacology & Chemical Biology Seminar Series
9/15/2022 - 12:00 PM-1:00 PM
"The Novel Treatment of Engineered hACE-2 Decoy Peptide to SARS-CoV-2 & Its Variants-Induced Acute Lung Injury"
Lianghui (Lucy) Zhang, M.D., Ph.D.
Assistant Professor of Medicine
Division of Pulmonary, Allergy, Critical Care Medicine
Vascular Medicine Institute
University of Pittsburgh School of Medicine
“Continuing emergence of SARS-CoV-2 variants of concern that may escape vaccine-induced immune responses highlight the urgent need for effective COVID-19 therapeutics.
We identified an engineered soluble ACE2 protein (sACE22.v2.4-IgG1), which markedly augmented the affinity for the S protein of the SARS-CoV-2 multiple variants of concern (VOCs): B.1.1.7 (Alpha), B.1.351 (Beta), P.1 (Gamma), B.1.617.2 (Delta), and B.1.1.529 (omicron). We demonstrated prophylactic and therapeutic injections of sACE22.v2.4-IgG1 prevented lung vascular injury and edema formation induced by SARS-CoV-2 VOCs including omicron
.
Furthermore, we found that
the catalytic activity of the decoy receptor is required for its therapeutic efficacy to increase survival of SARS-CoV-2 infected K18-hACE2 transgenic mice."
Pharmacology & Chemical Biology Seminar Series
9/22/2022 - 12:00 PM-1:00 PM
"EROS: controlling the phagocyte respiratory burst and purinergic signaling"
Dr David Thomas MA MB BChir PhD MRCP
(Neph)
Reader in Immunity and Inflammation and Honorary, Consultant Nephrologist
Wellcome-Beit Clinical Research Career Dev Fellow, Imperial College London
I will outline our characterisation of EROS (
CYBC1
gene), a hitherto undescribed protein that acts as a super-selective chaperone for the gp91
phox
subunit of the phagocyte NADPH oxidase as well as the ATP receptor P2X7. EROS-deficiency in both mouse and human causes a severe immunodeficiency. The talk will focus on its discovery, role in immune physiology and molecular mechanism of action.
Pharmacology & Chemical Biology Seminar Series
9/29/2022 - 12:00 PM-1:00 PM
“The cell biology of heme trafficking and a new role for NO in its regulation”
Dennis Stuehr, PhD
Professor, Cleveland Clinic, Lerner Research Institute
Heme is an important form of biologically active iron in cells. Heme levels participate in cell signaling and gene expression, and when bound in proteins enables various electron transfer, small molecule transport, and catalytic functions. Because the final steps of heme biosynthesis take place inside the mitochondria and free heme is toxic, mechanisms exist to carefully control its level and to enable its transport and delivery to the many hemeproteins that mature and function outside of the mitochondria. Moreover, evidence is emerging to suggest that differences in heme allocation and homeostasis influence important aspects of cancer progression and inflammation. Our lab is identifying the proteins that help to deliver heme and insert it into proteins, and uncovering the mechanisms that regulate these processes. The talk will highlight key roles for GAPDH and chaperone hsp90 in driving heme delivery and insertion into various targets including sGC, hemoglobin, myoglobin, NOS, and Trp dioxygenases, and will show how biologic NO can either up- or down-regulate these processes, depending on its flux. Overall, these findings may help explain how heme homeostasis is achieved in cells and can become dysregulated in disease.
Pharmacology & Chemical Biology Seminar Series
10/6/2022 - 12:00 PM-1:00 PM
“Mechanisms of beige adipocyte formation and maintenance”
Yuwei Jiang, PhD
Assistant Professor
Department of Physiology and Biophysics
University of Illinois at Chicago
The induction of thermogenic beige adipocytes in white adipose tissue is a promising avenue for the treatment of obesity and Type 2 diabetes. In this seminar, I will discuss the cell origins of beige adipocytes, and then present a novel mechanism regulating beige adipocyte formation and maintenance that could be developed therapeutically.
Pharmacology & Chemical Biology Seminar Series
10/20/2022 - 12:00 PM-1:00 PM
“cAMP signaling at the nanometer scale”
Prof. Dr. Andreas Bock
Medical Faculty
Leipzig University
Rudolf-Boehm-Institute of Pharmacology and Toxicology
G protein-coupled receptors (GPCRs) form the largest family of cell membrane receptors and modulate almost any (patho)physiological process in humans. GPCR signaling involves activation of distinct G-protein families, modulation of multiple intracellular second messengers, such as cAMP, and activation of kinases. Therefore, GPCRs orchestrate overwhelmingly complex intracellular signaling networks that are capable of precisely relaying signals in space and time to exert a myriad of specific cell functions.
To ensure signaling specificity, GPCRs and their downstream signals are compartmentalized in very small regions in the cell that are called
nanodomains
. In my talk, I will introduce the concept of signaling compartmentation and highlight our recent work on cAMP nanodomains. Disruption of GPCR signaling networks can lead to noncommunicable diseases such as heart failure and cancer, and I will briefly discuss potential roles of nanodomain signaling in such diseases.
Pharmacology & Chemical Biology Seminar Series
11/3/2022 - 12:00 PM-1:00 PM
“mTOR in brain development and disease”
Mustafa Sahin, MD, PhD
Professor, Neurology
Harvard Medical School
Dr. Sahin will discuss the role of TSC1 and TSC2 proteins in regulating various neuronal functions through mTOR in cell culture and animal models and the implications of the basic research for developing therapies for clinical indications.
Pharmacology & Chemical Biology Seminar Series
11/10/2022 - 12:00 PM-1:00 PM
“Discovering new signaling pathways for the calcineurin phosphatase"
Martha Cyert, PhD
Chair, Department of Biology
Stanford University
We are systematically discovering signaling pathways for Calcineurin, the calcium/calmodulin regulated phosphatase and target of immunosuppressants FK506 and Cyclosporin A. Using in silico and experimental approaches we are demonstrating new roles for calcineurin in Notch signaling, phosphoinositide signaling, at the nuclear pore and at centrosomes and cilia.
Pharmacology & Chemical Biology Seminar Series
12/1/2022 - 12:00 PM-1:00 PM
“Interplay of chromatin remodelling and nuclear receptor networks in breast cancers”
Sankari Nagarajan, PhD
Lecturer in Chromatin Biology
University of Manchester
Pharmacology & Chemical Biology Seminar Series
12/8/2022 - 12:00 PM-1:00 PM
“Structural basis of LRRK2 activation – a molecular paradigm of kinase spatial regulation”
Ji Sun, PhD
Assistant Member
St. Jude Children’s Research Hospital
Gain-of-function mutations in
LRRK2
lead to Parkinson’s Disease (PD); therefore, LRRK2 inhibitors hold great potential for PD treatment. In this seminar, Dr. Sun will discuss the structure-function relationship of LRRK2, focusing on the following questions. 1) What is the architecture of LRRK2, a 286-kDa multi-domain protein? 2) How is LRRK2 recruited to membrane surface by Rab GTPase? 3) How is LRRK2 activated upon membrane recruitment. And 4) What can we learn about LRRK2 PD mutations to guide future drug development?
Pharmacology & Chemical Biology Seminar Series
12/15/2022 - 12:00 PM-1:00 PM
“The secret life of G proteins”
Mikel Garcia-Marcos, PhD
Professor
Department of Biochemistry
Boston University School of Medicine
Our research program aims to understand the mechanisms and consequences cell communication via heterotrimeric G-proteins (Gαβγ) because they represent major intracellular hubs of signaling with very direct biomedical relevance. To achieve this goal, we use a wide range of approaches (biochemistry, cell biology, genetics, drug screening/ development) and experimental systems (purified proteins, cultured cells, model organisms) in combination with the development of novel tools (biosensors, chemogenetics, optogenetics). Our ongoing efforts have direct implications in cancer, embryonic development defects, and neurological disorders.
Calendar